Half-year Report

Imperial Brands Finance PLC
14 June 2023
 

Company Number: 03214426

 

 

 

 

 

 

 

 

 

IMPERIAL BRANDS FINANCE PLC

Interim Financial Statements 2023



 

INTERIM MANAGEMENT REPORT

For the six months ended 31 March 2023

 

The Directors present their Interim Management Report together with the condensed unaudited Interim Financial Statements of Imperial Brands Finance PLC ("the Company") for the six months ended 31 March 2023.

Business review and performance

The principal activity of the Company is to provide treasury services to Imperial Brands PLC and its subsidiaries ("the Group").  There have been no changes in the composition of the Company in the interim period.

The performance of the Company is dependent on external borrowings and intragroup loans payable and receivable and interest thereon, together with fair value gains and losses on derivative financial instruments.

The profit for the six months ended 31 March 2023 was £277 million (2022: loss of £81 million) and is stated after a release of £73 million (2022: charge of £168 million) arising on a decrease in the expected credit loss provision against the carrying value of certain loans made to entities within the Imperial Brands Group.  The expected loss provision arises due to the assessment of credit risk associated with the future repayment of the loans.  The decision to exit operations in Russia during the 2022 fiscal year has had an impact on the recoverability of one other intragroup loan.  The release of the provision is not tax allowable and therefore there is no associated tax credit.  Total shareholders' funds as at 31 March 2023 were £2,561 million (2022: £2,232 million).

The directors do not recommend a dividend for the current period.  There were no aggregate dividends on the ordinary shares recognised as a charge to shareholders' funds during the six months ended 31 March 2023 (2022: £nil).

Principal risks and uncertainties

The Company is a wholly owned indirect subsidiary of Imperial Brands PLC, which is the ultimate parent company within the Group, and the Directors of the Group manage operations at a Group level.  The Company, as the main financing and financial risk management company for the Group, undertakes transactions to manage the Group's financial risks, together with its financing and liquidity requirements.

The principal risks and uncertainties of the Company are discussed in note 20 of the Company's Annual Report and Accounts for the year ended 30 September 2022, which does not form part of this report, but is available at www.imperialbrandsplc.com.  These risks and uncertainties remain materially unchanged as at 31 March 2023.

LIBOR

Following the announcement of the discontinuation of GBP LIBOR at the end of 2021 and USD LIBOR discontinuation in 2023, the Company amended its bank facility agreement on 28 September 2021 to stop referencing GBP and USD LIBOR and instead reference the daily risk free rates of SONIA and SOFR respectively. In the first half of the previous fiscal year all GBP LIBOR derivatives were changed to reference SONIA instead of GBP LIBOR.  All USD LIBOR derivatives were changed to reference SOFR instead of USD LIBOR by May 2023. There are no changes pending for EUR derivatives.

Outlook

The business activity is expected to continue at levels similar to the current level. The Company will continue to manage the overall liquidity and financial risk management requirements of the Group as they change over time. The Company will manage the Group's financing requirement in combination with other Group entities where it is beneficial to the Group as a whole.

Going concern

The Directors are satisfied that the Company has adequate resources to meet its operational needs for the foreseeable future and accordingly they continue to adopt the going concern basis in preparing these Interim Financial Statements.

Directors' responsibility statement

The Board of Directors comprising L J Paravicini, M E Slade and D M Tillekeratne, confirms that:

●  the condensed Interim Financial Statements have been prepared in accordance with applicable accounting standards and give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company as required by Rule 4.2.4 of the Disclosure Transparency Rules of the United Kingdom's Financial Conduct Authority ("the DTRs"); and

the Interim Management Report includes a fair review of the information required by Rule 4.2.7 of the DTRs, namely an indication of important events that have occurred during the six months ended 31 March 2023 and their impact on the condensed set of Interim Financial Statements, and a description of the principal risks and uncertainties for the remaining six months of the year.

By order of the Board

 

 

 

M E Slade                                             D M Tillekeratne

Director                                                 Director

1 June 2023                                                 1 June 2023

INTERIM FINANCIAL STATEMENTS

For the six months ended 31 March 2023

 

 

Income Statement



Unaudited

Unaudited

Audited

(In £ million)

Notes

6 months ended 31 March 2023

6 months ended 31 March 2022

Year ended 30

September 2022

Other operating income


-

-

1

Administrative expenses


(1)

(1)

(3)

Impairment gain/(loss)


73

(168)

(245)

Operating profit/(loss)


72

(169)

(247)

Investment income

2

1,516

1,040

2,888

Finance costs

3

(1,254)

(932)

(2,618)

Profit/(loss) before taxation


334

(61)

23

Tax on profit

4

(57)

(20)

(52)

Profit/(loss) for the period


277

(81)

(29)

 

All activities derive from continuing operations.

The Company has no other comprehensive income other than that included above and, therefore, no separate Statement of Comprehensive Income has been presented.

Balance Sheet


 



 



Unaudited

Unaudited

Audited

(£ million)

Notes

31 March 2023   

31 March 2022

30 September 2022

Non-current assets


 



Other receivables

7

-

44

44

Derivative financial instruments

6

694

179

985



694

223

1,029

Current assets


 



Other receivables

29,988

28,446

28,846

Cash and cash equivalents


28

23

1,161

Derivative financial instruments

6

72

93

54



30,088

28,562

30,061

Total assets


30,782

28,785

31,090

Current liabilities


 



Borrowings


(1,851)

(1,669)

(985)

Derivative financial instruments

6

(579)

(276)

(54)

Trade and other payables


(16,584)

(16,040)

(17,704)



(19,014)

(17,985)

(18,743)

Non-current liabilities


 



Borrowings


(6,977)

(7,139)

(8,110)

Derivative financial instruments

6

(832)

(592)

(1,071)



(1,398)

(837)

(882))



(9,207)

(8,568)

(10,063)

Total liabilities


(28,221)

(26,553)

(28,806)

Net assets


2,561

2,232

2,284

 


 



Equity


 



Share capital


2,100

2,100

2,100

Retained earnings


461

132

184

Total equity


2,232

2,284

 



 

Statement of Changes in Equity (unaudited)

 

 

 

£ million

 

 

 

 

Share

capital

Retained

earnings

Total

equity

At 1 October 2022

 

 

 

 

2,100

184

2,284

Profit for the period

 

 

 

 

-

277

277

Total comprehensive income

 

 

 

 

-

277

277

At 31 March 2023

 

 

 

 

2,100

461

2,561

 

 

 

 

 

 

 

 

 

 

 

 

 

Unaudited

 

 

 





Share

capital

Retained

earnings

Total

equity

At 1 October 2021





2,100

213

2,313

Loss for the period





-

(81)

(81)

Total comprehensive loss





-

(81)

(81)

At 31 March 2022





2,100

132

2,232



 

NOTES TO THE INTERIM FINANCIAL STATEMENTS

For the six months ended 31 March 2023

 

1. Accounting Policies

These condensed Interim Financial Statements have been prepared on the going concern basis and in accordance with the United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including the Companies Act 2006 and FRS 101.

Basis of Preparation

The condensed Interim Financial Statements comprise the unaudited results for the six months ended 31 March 2023 and 31 March 2022, together with the audited results for the year ended 30 September 2022.

The information shown for the year ended 30 September 2022 does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006, and is an abridged version of the Company's Financial Statements for that year.  The Auditors' Report on those Financial Statements was unqualified and did not contain any statements under section 498 of the Companies Act 2006.  The Financial Statements for the year ended 30 September 2022 were approved by the Board of Directors on 1 December 2022 and filed with the Registrar of Companies.

This condensed set of Interim Financial Statements for the six months ended 31 March 2023 has been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority and FRS 104 'Interim Financial Reporting' ("FRS 104") as adopted by the Financial Reporting Council ("FRC") using the recognition and measurement requirements of FRS 100 'Application of Financial Reporting Requirements' ("FRS 100") and FRS 101 'Reduced Disclosure Framework' ("FRS 101").  The condensed set of Interim Financial Statements for the six months ended 31 March 2023 should be read in conjunction with the Annual Report and Financial Statements for the year ended 30 September 2022.

The Company has taken advantage of the following disclosure exemptions under FRS 101 on the basis that the disclosures are available within the consolidated financial statements of the ultimate parent company, which is Imperial Brands PLC:

a)   the requirement in paragraph 38 of IAS 1 Presentation of Financial Statements to present comparative information in respect of paragraph 79(a)(iv) of IAS 1 Presentation of Financial Statements.

b)    the requirements of paragraphs 10(d) and 10(f) of IAS 1 Presentation of Financial Statements.

c)    the requirements of IAS 7 Statement of Cash Flows

d)    the requirements of paragraph 17 of IAS 24 Related Party Disclosures.

e)    the requirements in IAS 24 Related Party Disclosures to disclose related party transactions entered into between two or more members of a group, provided that any subsidiary which is a party to the transaction is wholly owned by such a member.

The Imperial Brands PLC consolidated financial statements may be found in via the investor relations section of the Imperial Brands PLC website at www.imperialbrandsplc.com/investors.

The Interim Financial Statements have been prepared on an amortised cost or fair value basis as described in the accounting policies on derivative financial instruments below

The Company is a wholly owned indirect subsidiary of Imperial Brands PLC and is included in the consolidated Financial Statements of Imperial Brands PLC. Consequently, the Company has taken advantage of the exemption conferred by FRS 101 paragraph 8(h) and not presented a cash flow statement.

 

2. Investment income

 


Unaudited

Unaudited

Audited

(In £ million)

6 months ended 31 March 2023   

6 months ended 31 March 2022

Year ended 30 September 2022

Interest receivable from Group undertakings

656

252

487

Interest on bank deposits and other loan receivables

4

-

3

Exchange gains on monetary assets and liabilities

491

100

-

Fair value gains on external derivative financial instruments

365

688

1,483

Fair value gains on intragroup derivative financial instruments

-

-

915


1,516

1,040

2,888

 

 

 

 

 

3. Finance costs

 


Unaudited

Unaudited

Audited

(In £ million)

6 months ended 31 March 2023   

6 months ended 31 March 2022

Year ended 30 September 2022

Interest payable to Group undertakings

282

55

125

Interest on bank loans and other loan payables

181

148

297

Exchange losses on monetary assets and liabilities

-

-

983

Fair value losses on external derivative financial instruments

273

616

1,213

Fair value losses on intragroup derivative financial instruments

518

113

-


1,254

932

2,618

 

4. Tax on profit

 

Analysis of charge in the period:


Unaudited

Unaudited

Audited

(In £ million)

6 months ended 31 March 2023   

6 months ended 31 March 2022

Year ended 30 September 2022

UK Corporation tax on profits for the period

57

20

51

Withholding tax

-

-

1

Double taxation relief

-

-

(1)

Adjustments in respect of prior years

-

-

1

Current tax

57

20

52

Total taxation

57

20

52

 

5. Fair value of financial assets and liabilities

There are no material differences between the carrying value of the Company's financial assets and liabilities and their estimated fair value, with the exception of bonds.  The fair value of bonds is estimated to be £7,869 million (2022: £7,963 million) and has been determined by reference to market prices at the balance sheet date.  The carrying value of bonds is £8,234 million (2022: £7,899 million).  The fair value of all other borrowings is considered to be equal to their carrying amount.

 

6. Derivative financial instruments

 


Unaudited

Unaudited

Audited

 (In £ million)

6 months ended 31 March 2023   

6 months

 ended 31

 March 2022

Year ended 30 September 2022

Assets




Interest rate swaps

604

190

686

Foreign exchange contracts

10

21

31

Intragroup forward foreign currency contracts

-

35

-

Cross currency swaps

152

26

322

Total carrying value of derivative financial assets

766

272

1,039

Liabilities

 



Interest rate swaps

(621)

(480)

(782)

Foreign exchange contracts

(29)

(16)

(13)

Intragroup forward foreign currency contracts

(414)

(227)

-

Cross currency swaps                       

(347)

(179)

(342)

Total carrying value of derivative financial liabilities before collateral

(1,411)

(902)

(1,137)

Collateral

-

34

12

Total carrying value of derivative financial liabilities

(1,411)

(868)

(1,125)


 



Total carrying value of derivative financial instruments

(645)

(596)

(86)


 



Analysed as:

 



Interest rate swaps

(17)

(290)

(96)

Foreign exchange contracts

(19)

5

18

Intragroup forward foreign currency contracts

(414)

(192)

-

Cross currency swaps

(195)

(153)

(20)

Collateral

-

34

12

Total carrying value of derivative financial instruments

(645)

(596)

(86)

 

The Company's derivative financial instruments are held at fair value.  Fair values are determined based on observable market data such as yield curves and foreign exchange rates to calculate the present value of future cash flows associated with each derivative at the balance sheet date, and are consistent with those applied for the year ended 30 September 2022.

 

All financial assets and liabilities are carried on the balance sheet at amortised cost, other than derivative financial instruments which are carried at fair value.  Derivative fair values are determined based on observable market data such as yield curves, foreign exchange rates and credit default swap prices to calculate the present value of future cash flows associated with each derivative at the balance sheet date (Level 2 classification hierarchy per IFRS 7). Market data is sourced through Bloomberg and valuations are validated by reference to counterparty valuations where appropriate. Some of the Company's derivative financial instruments contain early termination options and these have been considered when assessing the element of the fair value related to credit risk.  On this basis the reduction in reported net derivative liabilities due to credit risk is £10 million (2022: £17 million) and would have been a £20 million (2022: £33 million) reduction without considering the early termination options.  There were no changes to the valuation methods or transfers between hierarchies during the year. With the exception of capital market issuance, the fair value of all financial assets and financial liabilities is considered approximate to their carrying amount.

 

7. Other receivables

 

 

Unaudited

6 months ended 31 March 2023

Unaudited

6 months ended 31 March 2022

Audited

Year ended 30 September

2022

(In £ million)

Current

Non-Current

Current

Non-current

Current

Non-Current

Amounts owed by Group undertakings

29,980

-

28,442

44

28,840

44

Other receivables and prepayments

8

-

4

-

6

-

 

29,988

-

28,442

44

28,846

44

 

Amounts owed by Group undertakings are unsecured, both interest bearing and non-interest bearing and can be either repayable on a future date to be mutually agreed between the Company and the counterparty borrower or have fixed repayment dates.  At 31 March 2023 £26,738 million (2022:  £25,322 million) of the amounts owed by Group undertakings is repayable on a mutually agreed future date (treated as a current receivable) and £3,242 million (2022: £3,164 million) were term loans.  There were £29,954 million (2022: £27,847 million) of interest bearing loans and £26 million (2022: £639 million) of non-interest bearing loans.  Where loans were subject to interest the rates charged varied from 0.131% to 13.750% (2022: 0.125% to 20.000%).

 

The Directors have assessed the extent to which amounts owed by the Group companies are impaired. For those balances that are neither overdue nor impaired the Directors have concluded that the expected credit losses (ECL) that are possible from default events over the next twelve months are immaterial and consequently no allowance for impairment has been recognised. For those balances assessed to be impaired, an expected credit loss adjustment of £535 million (2022: £660 million) has been recognised to reflect the credit risk inherent within a number of the current intragroup loans receivable, as follows:

 


 


31 March 2023



 

Gross amount

ECL allowance

Net balance

Group undertaking loan receivable balances that are not impaired

 

29,740

-

29,740

Group undertaking loan receivable balances that are impaired

 

775

(535)

240

 

 

30,515

(535)

29.980

 


 


31 March 2022



 

Gross amount

ECL allowance

Net balance

Group undertaking loan receivable balances that are not impaired

 

28,207

-

28,207

Group undertaking loan receivable balances that are impaired

 

939

(660)

279

 

 

29,146

(660)

28,486

 

 





 


30 September 2022



 

Gross amount

ECL allowance

Net balance

Group undertaking loan receivable balances that are not impaired

 

28,586

-

28,586

Group undertaking loan receivable balances that are impaired

 

906

(608)

298

 

 

29,492

(608)

28,884

 

The released provision in the period was £73 million (2022: charge of £168 million).

 

 

 

 

8. Related party transactions

The Company has taken advantage of the Group dispensation permitted under FRS 101 for 100% owned Group subsidiaries, not to disclose intragroup transactions undertaken during the period.

During the period the Company charged interest and other expenses to Compañía de Distribución Integral Logista S.A.U. to the value of €5 million (2022: €1 million).  At 31 March 2023, the Company had an outstanding balance receivable due from Compañía de Distribucion Integral Logista SAU totalling €515 million (2022: €442 million).

During the period the Company was charged interest to the value of €19 million by Logista France SAS (2022: €5 million).  At 31 March 2023, the Company had an outstanding balance payable to Logista France SAS totalling €1,349 million (2022: €1,419 million).

During the period the Company was charged interest to the value of €15 million by Logista Italia SpA (2022: €4 million).  At 31 March 2023, the Company had an outstanding balance payable to Logista Italia SpA totalling €1,057 million (2022: €1,124 million).

During the period the Company provided a temporary loan facility of £320 million to the Imperial Tobacco Pension Fund.  £200 million had been drawn down during the first half of October 2022 to support ongoing liquidity requirements within the Fund's Liability Driven Investment holdings during a period of volatility in the UK Government Bond market. The £200 million drawn down has been repaid by 31 March 2023.  The Company charged interest to the value of £2 million.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings